Skip to content

Vuzix VUZI Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp

Segments

By geography

See full
North America70%+25.0%
Europe20%-41.2%
Other Continent18%-33.3%
Asia Pacific8%+14.3%

By product

See full
Engineering Services72%+67.4%

Other financials

Income statement

See full
Revenue$1.4M-12.0%
Gross profit-$377.9K-42.5%
Operating income-$7.2M+17.9%
Net income-$7.1M+18.1%
EPS (diluted)-$0.09+18.2%

Balance sheet

See full
Cash & equivalents$20.2M+32.4%
Total debt$872.2K+143%
Total equity$24.0M-26.9%
Total assets$38.4M+7.3%

Cash flow

See full
Operating cash flow-$5.6M-60.9%
CapEx$996.4K+62.4%
Free cash flow-$6.6M-61.1%

Valuation

See full
Market cap$241.16M+9.8%
Enterprise value$221.86M+9.6%
P/S39.6×-0.1×

Profitability

See full
Gross margin-19.3%-8.7pp
Operating margin-507.9%-196pp
Net margin-504.1%-194pp
FCF margin-382.3%+2.4pp

Returns & leverage

See full
Return on equity-108%-18.5pp
Debt / equity0.0×
Current ratio6.2×-1.5×